Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.471, 2005-01, pp. : 13-13
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
ADHD poses a significant burden among US adults
Inpharma, Vol. 1, Iss. 1475, 2005-01 ,pp. :
Access to resources
Recommend
Methylphenidate approved for adults with ADHD in the US.
Inpharma, Vol. 1, Iss. 1645, 2008-01 ,pp. :
Central stimulant use in ADHD a burden in the US
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 436, 2003-01 ,pp. :
MS poses substantial employer burden
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 588, 2009-01 ,pp. :
Economic Burden of Epilepsy among the Privately Insured in the US
PharmacoEconomics, Vol. 28, Iss. 8, 2010-08 ,pp. :